CAPTRUST FINANCIAL ADVISORS - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 68 filers reported holding CASI PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$0
-100.0%
150
-90.0%
0.00%
Q1 2022$1,0000.0%1,5000.0%0.00%
Q4 2021$1,000
-50.0%
1,5000.0%0.00%
Q3 2021$2,0000.0%1,5000.0%0.00%
Q2 2021$2,000
-50.0%
1,5000.0%0.00%
Q1 2021$4,0000.0%1,5000.0%0.00%
Q4 2020$4,000
+100.0%
1,5000.0%0.00%
Q3 2020$2,000
-50.0%
1,5000.0%0.00%
Q2 2020$4,0001,5000.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Wellington Shields Capital Management, LLC 2,188,547$1,751,0000.22%
Wellington Shields & Co., LLC 1,141,190$913,0000.18%
Ikarian Capital, LLC 1,223,067$978,0000.15%
Ground Swell Capital, LLC 18,638$15,0000.09%
Anson Funds Management LP 267,507$214,0000.02%
Sterneck Capital Management, LLC 40,000$32,0000.02%
FEDERATED HERMES, INC. 10,150,000$8,120,0000.02%
Roundview Capital LLC 122,453$98,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,677,146$1,342,0000.01%
RBF Capital, LLC 159,367$127,0000.01%
View complete list of CASI PHARMACEUTICALS INC shareholders